Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash, cash equivalents and restricted cash	$ 892,844	$ 642,095
Short-term investments	29,490	236,882
Accounts receivable, net of allowance of $6,252 and $6,481 at September 30, 2024 and December 31, 2023, respectively	306,876	278,289
Inventory	48,724	40,759
Prepaid expenses and other current assets, net	44,631	60,524
Total current assets	1,322,565	1,258,549
Property and equipment, net	142,170	111,210
Operating lease right-of-use assets	87,856	56,537
Other assets	38,356	15,403
Total assets	1,590,947	1,441,699
Current liabilities:
Accounts payable	27,834	14,998
Accrued compensation	49,051	45,857
Other accrued liabilities	126,176	149,405
Deferred revenue, current portion	17,886	16,612
Short-term debt financing	80,469	80,402
Total current liabilities	301,416	307,274
Long-term debt financing	286,549	282,945
Deferred revenue, long-term portion and other liabilities	25,504	19,128
Operating lease liabilities, long-term portion	98,953	67,025
Total liabilities	712,422	676,372
Commitments and contingencies (Note 8)
Stockholders' equity:
Common stock, $0.0001 par value: 750,000 shares authorized at both September 30, 2024 and December 31, 2023; 124,137 and 119,581 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	12	11
Additional paid-in capital	3,393,369	3,145,837
Accumulated deficit	(2,514,091)	(2,377,436)
Accumulated other comprehensive loss	(765)	(3,085)
Total stockholders' equity	878,525	765,327
Total liabilities and stockholders' equity	$ 1,590,947	$ 1,441,699